Dopamine d2 Receptor Antikörper (C-Term) (PE)
Kurzübersicht für Dopamine d2 Receptor Antikörper (C-Term) (PE) (ABIN2255729)
Target
Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 306-336, C-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- DRD2, CT (DRD2, D(2) dopamine receptor, Dopamine D2 receptor) (PE)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- DRD2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 306-336 amino acids from the C-terminal region of human DRD2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 4°C ,Do Not Freeze
-
-
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Andere Bezeichnung
- DRD2
-
NCBI Accession
- NP_057658, NP_000786
-
UniProt
- P14416
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Target
-